Literature DB >> 15908694

The formation of a salt bridge between helices 3 and 6 is responsible for the constitutive activity and lack of hormone responsiveness of the naturally occurring L457R mutation of the human lutropin receptor.

Meilin Zhang1, Dario Mizrachi, Francesca Fanelli, Deborah L Segaloff.   

Abstract

The human lutropin receptor (hLHR) plays a pivotal role in reproductive endocrinology. A number of naturally occurring mutations of the hLHR have been identified that cause the receptor to become constitutively active. To gain further insights into the structural basis for the activation of the hLHR by activating mutations, we chose to examine a particularly strong constitutively activating mutation of this receptor, L457R, in which a leucine that is highly conserved among rhodopsin-like G protein-coupled receptors in helix 3 has been substituted with arginine. Using both disruptive as well as reciprocal mutagenesis strategies, our studies demonstrate that the ability of L457R to stabilize an active form of the hLHR is because of the formation of a salt bridge between the replacing amino acid and Asp-578 in helix 6. Such a lock between the transmembrane portions of helices 3 and 6 is concurrent with weakening the connections between the cytosolic ends of the same helices, including the interaction found in the wild-type receptor between Arg-464, of the (E/D)R(Y/W) motif, and Asp-564. This structural effect is properly marked by the increase in the solvent accessibility of selected amino acids at the cytosolic interfaces between helices 3 and 6. The integrity of the conserved amino acids Asn-615 and Asn-619 in helix 7 is required for the transfer of the structural change from the activating mutation site to the cytosolic interface between helices 3 and 6. The results of in vitro and computational experiments further suggest that the structural trigger of the constitutive activity of the L457R mutant may also be responsible for its lack of hormone responsiveness.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15908694      PMCID: PMC1237128          DOI: 10.1074/jbc.M502102200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

Review 1.  Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors.

Authors:  J A Ballesteros; L Shi; J A Javitch
Journal:  Mol Pharmacol       Date:  2001-07       Impact factor: 4.436

Review 2.  Efficacy at G-protein-coupled receptors.

Authors:  Terry Kenakin
Journal:  Nat Rev Drug Discov       Date:  2002-02       Impact factor: 84.694

3.  Desensitization of Gs-coupled receptor signaling by constitutively active mutants of the human lutropin/choriogonadotropin receptor.

Authors:  Hiromitsu Shinozaki; Viktor Butnev; Ya-Xiong Tao; Kok Long Ang; Marco Conti; Deborah L Segaloff
Journal:  J Clin Endocrinol Metab       Date:  2003-03       Impact factor: 5.958

4.  Pleiotropic effects of substitutions of a highly conserved leucine in transmembrane helix III of the human lutropin/choriogonadotropin receptor with respect to constitutive activation and hormone responsiveness.

Authors:  H Shinozaki; F Fanelli; X Liu; J Jaquette; K Nakamura; D L Segaloff
Journal:  Mol Endocrinol       Date:  2001-06

5.  Gonadotropin-independent precocious puberty due to luteinizing hormone receptor mutations in Brazilian boys: a novel constitutively activating mutation in the first transmembrane helix.

Authors:  A C Latronico; H Shinozaki; G Guerra; M A Pereira; S H Lemos Marini; M T Baptista; I J Arnhold; F Fanelli; B B Mendonca; D L Segaloff
Journal:  J Clin Endocrinol Metab       Date:  2000-12       Impact factor: 5.958

Review 6.  The lutropin/choriogonadotropin receptor, a 2002 perspective.

Authors:  Mario Ascoli; Francesca Fanelli; Deborah L Segaloff
Journal:  Endocr Rev       Date:  2002-04       Impact factor: 19.871

7.  Chimeras of the rat and human FSH receptors (FSHRs) identify residues that permit or suppress transmembrane 6 mutation-induced constitutive activation of the FSHR via rearrangements of hydrophobic interactions between helices 6 and 7.

Authors:  Ya-Xiong Tao; Dario Mizrachi; Deborah L Segaloff
Journal:  Mol Endocrinol       Date:  2002-08

Review 8.  A molecular dissection of the glycoprotein hormone receptors.

Authors:  Gilbert Vassart; Leonardo Pardo; Sabine Costagliola
Journal:  Trends Biochem Sci       Date:  2004-03       Impact factor: 13.807

9.  The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints.

Authors:  Robert Fredriksson; Malin C Lagerström; Lars-Gustav Lundin; Helgi B Schiöth
Journal:  Mol Pharmacol       Date:  2003-06       Impact factor: 4.436

10.  Insight into mutation-induced activation of the luteinizing hormone receptor: molecular simulations predict the functional behavior of engineered mutants at M398.

Authors:  Francesca Fanelli; Miriam Verhoef-Post; Marianna Timmerman; Annelieke Zeilemaker; John W M Martens; Axel P N Themmen
Journal:  Mol Endocrinol       Date:  2004-03-11
View more
  20 in total

1.  Revisiting and questioning functional rescue between dimerized LH receptor mutants.

Authors:  Meilin Zhang; Rongbin Guan; Deborah L Segaloff
Journal:  Mol Endocrinol       Date:  2012-03-08

2.  Cell adhesion receptor GPR133 couples to Gs protein.

Authors:  Jens Bohnekamp; Torsten Schöneberg
Journal:  J Biol Chem       Date:  2011-10-24       Impact factor: 5.157

3.  Bioluminescence resonance energy transfer studies reveal constitutive dimerization of the human lutropin receptor and a lack of correlation between receptor activation and the propensity for dimerization.

Authors:  Rongbin Guan; Xiuyan Feng; Xueqing Wu; Meilin Zhang; Xuesen Zhang; Terence E Hébert; Deborah L Segaloff
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

Review 4.  Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics.

Authors:  Ya-Xiong Tao
Journal:  Pharmacol Ther       Date:  2008-08-09       Impact factor: 12.310

Review 5.  Insights learned from L457(3.43)R, an activating mutant of the human lutropin receptor.

Authors:  Ana Claudia Latronico; Deborah L Segaloff
Journal:  Mol Cell Endocrinol       Date:  2006-10-18       Impact factor: 4.102

6.  Conserved amino acids participate in the structure networks deputed to intramolecular communication in the lutropin receptor.

Authors:  Krassimira Angelova; Angelo Felline; Moon Lee; Manish Patel; David Puett; Francesca Fanelli
Journal:  Cell Mol Life Sci       Date:  2010-09-11       Impact factor: 9.261

7.  A cell surface inactive mutant of the human lutropin receptor (hLHR) attenuates signaling of wild-type or constitutively active receptors via heterodimerization.

Authors:  Meilin Zhang; Xiuyan Feng; Rongbin Guan; Terence E Hébert; Deborah L Segaloff
Journal:  Cell Signal       Date:  2009-07-16       Impact factor: 4.315

8.  Structural determinants underlying constitutive dimerization of unoccupied human follitropin receptors.

Authors:  Rongbin Guan; Xueqing Wu; Xiuyan Feng; Meilin Zhang; Terence E Hébert; Deborah L Segaloff
Journal:  Cell Signal       Date:  2009-09-30       Impact factor: 4.315

9.  Misfolding Ectodomain Mutations of the Lutropin Receptor Increase Efficacy of Hormone Stimulation.

Authors:  E Charmandari; R Guan; M Zhang; L G Silveira; Q R Fan; G P Chrousos; A C Sertedaki; A C Latronico; D L Segaloff
Journal:  Mol Endocrinol       Date:  2015-11-10

10.  APH1 polar transmembrane residues regulate the assembly and activity of presenilin complexes.

Authors:  Raphaëlle Pardossi-Piquard; Seung-Pil Yang; Soshi Kanemoto; Yongjun Gu; Fusheng Chen; Christopher Böhm; Jean Sevalle; Tong Li; Philip C Wong; Frédéric Checler; Gerold Schmitt-Ulms; Peter St George-Hyslop; Paul E Fraser
Journal:  J Biol Chem       Date:  2009-04-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.